**Core Concept**
Pyrimidine overproduction can lead to various metabolic disorders due to the accumulation of pyrimidine intermediates in the biosynthetic pathway. This can result in the excretion of abnormal amounts of these intermediates in the urine.

**Why the Correct Answer is Right**
Pyrimidine overproduction typically involves the overactivity of enzymes involved in the pyrimidine biosynthesis pathway, such as carbamoyl phosphate synthetase II (CPSII) or aspartate transcarbamylase (ATCase). This can lead to the accumulation of orotic acid, a pyrimidine intermediate, which is then excreted in the urine, resulting in orotic aciduria. However, pyrimidine overproduction does not directly lead to hyperuricemia, which is associated with purine metabolism disorders. Reye syndrome is a rare but serious condition associated with mitochondrial dysfunction and is not directly linked to pyrimidine overproduction. Megaloblastic anemia is a condition characterized by the production of abnormally large red blood cells and can be caused by impaired DNA synthesis, which can be a result of pyrimidine deficiency, not overproduction.

**Why Each Wrong Option is Incorrect**
**Option B:** Reye syndrome is a mitochondrial disorder that affects fatty acid metabolism and is not directly related to pyrimidine overproduction.
**Option D:** Megaloblastic anemia is typically caused by a deficiency of vitamin B12 or folate, which are essential for DNA synthesis, and not by pyrimidine overproduction.

**Clinical Pearl / High-Yield Fact**
It's essential to distinguish between pyrimidine and purine disorders, as they have distinct clinical and biochemical features. Pyrimidine disorders often involve the accumulation of specific pyrimidine intermediates, whereas purine disorders typically lead to the accumulation of uric acid.

**✓ Correct Answer: A. Hyperuricemia**